Transit Therapeutics, Inc.
PrivateCompany Overview
Transit Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Woodside, California. It was founded in 2025.
Transit Therapeutics, Inc. is a biotechnology company that develops protein-free trans-splicing of pre-mRNA to create therapeutic treatments for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transit Therapeutics, Inc. Comparables
Compare Transit Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tacit Therapeutics | 87% | |
| Ascidian Therapeutics | 81% | |
| Amber Bio | 79% |
For institutional investors. Book with your work email.
Transit Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Transit Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Transit Therapeutics, Inc.'s valuation, stock price, and market status.
Is Transit Therapeutics, Inc. a public or private company?
Transit Therapeutics, Inc. is a private company.
What is the current stock price of Transit Therapeutics, Inc.?
Transit Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Transit Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Transit Therapeutics, Inc. worth (valuation)?
Valuation information for Transit Therapeutics, Inc. is not publicly available.
Can I buy Transit Therapeutics, Inc. stock?
Transit Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Transit Therapeutics, Inc.'s last funding round?
Funding round information for Transit Therapeutics, Inc. is not publicly available.
Who are the main investors in Transit Therapeutics, Inc.?
Investor information for Transit Therapeutics, Inc. is not publicly disclosed.
Will Transit Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Transit Therapeutics, Inc..
How can I track Transit Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Transit Therapeutics, Inc.'s shares on secondary markets.